Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sire Bioscience Inc. C.SIRE

Healthcare Drug Manufacturers - Major Cannabis
SIRE BIOSCIENCE is a Life Science company and a Health Canada License holder under the Cannabis Act and the Industrial Hemp Regulations. SIRE owns 50 Acres of prime agricultural land in Leamington, ON, consisting of 137,000 sq ft greenhouse.


CSE:SIRE - Post by User

Sire Bioscience Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(6)
•••
Post by IntelInvestoron Jul 02, 2020 11:25am
305 Views
Post# 31215895

Technical Analysis Summary: BUY

Technical Analysis Summary: BUYTradingView's technical analysis summary for Sire Bioscience is BUY:

https://www.tradingview.com/symbols/CSE-SIRE/

Today is is UP 25% on stronger than average daily volume.

GLTA!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities